Optimizing treatment expectation in chronic low back pain by observing others: a fully balanced placebo desig

Not Applicable

• Conditions: M54; F45.41; Dorsalgia

• Registration Number: DRKS00024418
• Lead Sponsor: Bereichs Schmerzmedizin und SchmerzpsychologieUniversitätsklinikum Hamburg-Eppendorf (UKE)?Zentrum für Anästhesiologie und Intensivmedizin?Klinik und Poliklinik für Anästhesiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

chronic low back pain

Exclusion Criteria

Other chronic pain, which is more relevant for the patient,
Insufficient knowledge of German,
Patient is unable to give consent (e.g. incompliance or dementia),
Severe depressive symptoms,
Low back pain due to tumor disease,
cognitive limitations,
Health condition does not allow participation due to medical reasons,
hereditary galactose intolerance,
lactase deficiency
glucose-galactose malabsorption,
Chronic diseases that are mainly responsible for disability (e.g. rheumatic diseases, cancer, severe heart disease),
Pain-related red flags (Koes et al., 2010),
inflammatory or neuropathic back pain,
severe acute or chronic psychiatric illness (e.g., psychotic episodes),
Pregnancy
Koes BW, van Tulder M, Lin CW, Macedo LG, Mc Auley J, Maher C (2010) An updated overview of clinical guidelines for the management of
non- specific low back pain in primary care. Eur Spine J 19(12):2075-94.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Averaged pain on a numeric rating scale (NRS) 0-10 (0 = no pain and 10 = worst pain imaginable)

Secondary Outcome Measures

Name	Time	Method
physical capacity, pain medication consumption, expectations